Pharmafile Logo

X-Chem

X-Chem Strengthens Its Data-Driven Discovery Services

With new CBO appointment industry veteran Paul Davie joins X-Chem executive team to lead strategic growth and partnerships 20 June 2024 -- Massachusetts, US -- Small molecule drug discovery acceleration experts and DNA-encoded library (DEL) technology pioneers X-Chem welcomes Paul Davie as chief business officer. He will lead global business development, focusing on the creation...

X‑Chem Adds Chief Technology Officer to Bolster Its Digital Drug Discovery Strategy 

2 April 2024 -- Massachusetts, US -- X-Chem, the leading provider of innovative solutions in early-stage drug discovery, today announced the addition of Dr Erin Davis as chief technology officer. Dr Davis brings extensive experience in the areas of data strategy, informatics, computational chemistry and software solutions in drug discovery. The addition of Dr Davis...

X-Chem and Structural Genomics Consortium Enter Into Collaboration to Unlock the Human Proteome and Promote Open Science

28 September 2023 -- Massachusetts, US -- X-Chem, a global leader in innovative drug discovery services, and the Structural Genomics Consortium (SGC), a public-private partnership dedicated to accelerating drug discovery through open science, announced that they have entered a collaboration aimed at creating new chemical tools to study human proteins. The goal is to generate DNA-encoded...
https://www.x-chemrx.com
info@x-chemrx.com
100 Beaver Street Waltham, MA 02453

781.419.6900